🔗 Share this article

This year's prestigious award in medical science has been granted for revolutionary discoveries that clarify how the body's defense network targets dangerous pathogens while protecting the body's own cells.

A trio of renowned scientists—Japan's Shimon Sakaguchi and American experts Dr. Brunkow and Fred Ramsdell—share this honor.

Their research identified unique "security guards" within the immune system that remove rogue immune cells capable of harming the organism.

The findings are now paving the way for new treatments for immune disorders and malignancies.

The winners will divide a monetary award valued at 11m SEK.

Decisive Findings

"Their work has been essential for comprehending how the body's defenses functions and why we don't all suffer from serious self-attack conditions," stated the chair of the Nobel Committee.

The trio's studies address a fundamental question: How does the defense system protect us from numerous infections while leaving our healthy cells intact?

Our immune system uses immune cells that scan for indicators of disease, including viruses and bacteria it has never encountered.

These cells employ sensors—known as recognition units—that are generated by chance in a vast number of variations.

That gives the immune system the capacity to combat a wide array of threats, but the randomness of the process unavoidably creates immune cells that can attack the body.

Protectors of the Immune System

Researchers earlier understood that some of these harmful defense cells were eliminated in the thymus—the site where white blood cells develop.

The latest Nobel Prize recognizes the discovery of regulatory T-cells—described as the body's "security guards"—which patrol the system to disarm any immune cells that assault the body's own tissues.

We know that this process malfunctions in autoimmune diseases such as juvenile diabetes, multiple sclerosis, and RA.

A Nobel panel added, "The findings have established a new field of investigation and accelerated the development of new treatments, for example for tumors and autoimmune diseases."

Regarding cancer, T-regs prevent the system from fighting the tumor, so research are focused on lowering their numbers.

In autoimmune diseases, experiments are testing boosting T-reg cells so the organism is not under attack. A comparable approach could also be effective in reducing the risks of transplanted organ rejection.

Innovative Experiments

Professor Shimon Sakaguchi, from Osaka University, performed tests on rodents that had their immune gland removed, leading to autoimmune disease.

The researcher demonstrated that introducing immune cells from other animals could prevent the illness—suggesting there was a mechanism for preventing immune cells from attacking the host.

Mary Brunkow, from the a research center in Seattle, and Fred Ramsdell, currently at Sonoma Biotherapeutics in a California city, were investigating an genetic immune disorder in rodents and people that resulted in the discovery of a gene vital for how T-regs operate.

"The pioneering work has uncovered how the body's defenses is kept in check by T-reg cells, stopping it from mistakenly targeting the body's own tissues," commented a leading biological science specialist.

"This work is a striking illustration of how fundamental physiological study can have broad implications for human health."